Home > Specialists > Cardiovascular Surgery > Dr. Xiaofeng Ye (叶晓峰)
Specialty & Clinical Focus:
Dr. Xiaofeng Ye is a cardiovascular surgeon at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, specializing in minimally invasive heart valve surgery, TAVR, robot-assisted mitral valve repair, beating-heart coronary bypass, atrial fibrillation surgery, congenital heart disease correction, and endovascular aortic procedures.
Professional Title & Qualifications:
Chief Physician
Associate Professor
Hospital & Department：
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine – Department of Cardiovascular Surgery
(address: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, 200025)
Dr. Xiaofeng Ye (叶晓峰) - Cardiovascular Surgery Specialist
Personal Biography
Dr. Xiaofeng Ye is a Chief Physician in Cardiovascular Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, with more than 20 years of clinical experience. His work focuses on heart valve disease, coronary artery disease, and major vascular conditions, particularly minimally invasive valve repair. Dr. Ye completed postdoctoral research at the Massachusetts Institute of Technology and undertook advanced training or academic exchange at Harvard Medical School, Cleveland Clinic, Texas Heart Institute, and the University of Lille. He has received national and Shanghai professional honors, participated in major national cardiovascular research projects, and contributed to peer-reviewed studies published in Nature Medicine, Nature Communications, and Science Advances.
Why Choose Dr. Xiaofeng Ye for Your Care
Dr. Xiaofeng Ye’s practice is particularly relevant to international patients seeking expert review of complex heart valve, coronary artery, or major vascular conditions before deciding whether to travel to Shanghai. As a Chief Physician in Cardiovascular Surgery at Ruijin Hospital, he has particular experience in TAVR, robot-assisted valve repair, beating-heart coronary bypass, atrial fibrillation surgery, and endovascular aortic procedures. His postdoctoral and advanced training at MIT, Harvard Medical School, Cleveland Clinic, and other international centers adds a strong research and cross-border perspective. A remote specialist review can help patients organize imaging, cardiac test results, prior treatment records, and key questions so they can better understand the specialist’s opinion and prepare for the next step.
Pre-Travel Case Review & Specialist Liaison
Planning cardiovascular care in another country is easier when the specialist has reviewed your case before travel. MedBridgeNZ coordinates medical-record preparation, translation coordination, client-authorized secure document transfer, and appointment communication with Dr. Xiaofeng Ye’s hospital team.
Through the arranged remote specialist-review pathway, Dr. Ye will review the submitted records, provide his independent clinical opinion and recommendations, and address the questions included with your case. This can help clarify potential next steps and whether an in-person hospital visit in Shanghai should be considered before flights and accommodation are finalized.
If you decide to proceed, MedBridgeNZ coordinates the appointment request, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative assistance for the hospital visit.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Xiaofeng Ye
Areas of Expertise
Transcatheter Aortic Valve Replacement (TAVR): Minimally invasive valve replacement delivered through the femoral artery for patients with severe aortic stenosis who may not be candidates for open surgery.
Minimally Invasive Mitral Valve Repair: Robot-assisted mitral valve repair using the Da Vinci system.
Tricuspid Valve Repair: Minimally invasive tricuspid valve repair or replacement for patients with moderate to severe tricuspid stenosis or regurgitation.
Minimally Invasive Coronary Artery Bypass Surgery: Beating-heart coronary artery bypass without cardiopulmonary bypass for coronary artery disease and myocardial infarction.
Minimally Invasive Atrial Fibrillation Surgery: Surgical ablation on a beating heart without cardiopulmonary bypass.
Minimally Invasive Congenital Heart Disease Correction: Repair of common congenital anomalies such as atrial septal defect.
Minimally Invasive Aortic and Endovascular Surgery: Endovascular stent procedures for conditions such as aortic dissection and penetrating aortic ulcer without open-chest surgery.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
3,800 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Oct 2020 – Present: Chief Physician, Professor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Oct 2018 – Present: Director, Minimally Invasive Therapy Center, Ruijin Hospital
Oct 2018 – Present: Deputy Director, Department of Cardiovascular Surgery, Ruijin Hospital
Oct 2015 – Oct 2020: Associate Chief Physician, Associate Professor, Ruijin Hospital
Aug 2014 – Oct 2015: Attending Physician, Lecturer, Ruijin Hospital
Feb 2009 – Jul 2012: Resident Physician, Teaching Assistant, Ruijin Hospital
Jul 2008 – Feb 2009: Resident Physician, Teaching Assistant, Zhongshan Hospital, Fudan University
Education & Training
PhD in Surgery, Fudan University
Master’s in Surgery, Huazhong University of Science and Technology
Bachelor of Clinical Medicine, Wenzhou Medical University
Jul 2023 – Aug 2023: Cleveland Clinic, under the mentorship of Prof. Marc Gillinov
Aug 2019: Texas Heart Institute, USA
Jun 2018 – Aug 2018: University of Lille, Faculty of Medicine, Heart Center, France
Apr 2014 – Aug 2014: Harvard Medical School, USA
Jul 2012 – Apr 2014: Massachusetts Institute of Technology, Postdoctoral Research under Prof. Robert Langer
Awards & Honors
2024 National “Good Doctor” Award
2021 Chinese Medical Science and Technology Award, Second Prize
2021 “Shanghai Pharma Xilin Talent Development” Award
2020 Nominee, Outstanding Specialist Physician of Shanghai
2019 Fellowship, American Association for Thoracic Surgery (AATS)
2017 “Good Doctor in Cardiovascular Surgery” Award (formerly the Golden Scalpel Award), Chinese Medical Doctor Association
2016 National Lillehei Award Recipient
2016 Selected for Shanghai Jiao Tong University “Double Hundred Talents Program”
Academic & Professional Memberships
Youth Committee Member, Cardiovascular Surgery Branch, Chinese Medical Doctor Association
Committee Member, Chinese Society for Thoracic and Cardiovascular Surgery
Committee Member, National Committee on Minimally Invasive Cardiovascular Surgery
Vice President, Cardiovascular Surgery Branch, Shanghai Medical Association
Committee Member, Cardiovascular Surgery Branch, Shanghai Medical Association
International Member, Society of Thoracic Surgeons (STS), USA
Member, Tissue Engineering and Regenerative Medicine International Society (TERMIS)
Reviewer for international SCI journals including Annals of Thoracic Surgery, Biomaterials, Tissue Engineering, Journal of Tissue Engineering, Regenerative Medicine, Acta Biomaterialia, and Artificial Organs
Research & Publications
2022.01–2025.01: National Science Fund for Distinguished Young Scholars – Tissue-Engineered Myocardium for Coronary Artery Disease
2017.01–2020.12: National Natural Science Foundation of China (General Program) – Mechanisms of MYDGF-Mediated Microenvironmental Influence on hPSC-CMs Transplantation Post-Myocardial Infarction
2016.01–2019.12: National Natural Science Foundation of China (General Program) – Biodegradable 3D Micro-Scaffold Blocks Guiding Excitation–Contraction Coupling of hPSC-CMs and Their Impact on Left Ventricular Function
Selected Peer-Reviewed Publications
Huang S, et al. A perfusable, multifunctional epicardial device improves cardiac function and tissue repair. Nat Med. 2021;27(3):480–490. PMID: 33723455
Long Q, et al. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury. Nat Commun. 2025;16(1):1909. PMID: 39994192
Shi H, et al. Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease. Sci Adv. 2020;6(25):eaaz3621. PMID: 32596444
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Xiaofeng Ye review my cardiovascular case before I travel to Shanghai?
Yes. Once your case has been accepted for the arranged remote specialist review, MedBridgeNZ coordinates the preparation, translation, and client-authorized transfer of your medical records, cardiac imaging, test results, treatment history, and questions. Dr. Ye will review the submitted materials, provide his independent clinical opinion and recommendations, and answer the questions included with the case. This pre-travel review can help you understand whether his stated clinical focus—such as minimally invasive valve surgery, TAVR, or beating-heart coronary bypass—matches the issues you want assessed before planning an in-person visit.
How can an international patient request an appointment with Dr. Xiaofeng Ye at Ruijin Hospital?
Start by submitting your available medical records and a clear summary of the questions you want the specialist to address. MedBridgeNZ coordinates record preparation, translation where needed, secure document transfer, and appointment communication with the relevant hospital team. After the remote review or hospital triage process, we can assist with an in-person appointment request in Shanghai and coordinate the practical steps around the visit. Appointment timing remains subject to the hospital’s scheduling process and the specialist’s availability.
What support does MedBridgeNZ provide for medical travel to Shanghai?
MedBridgeNZ coordinates the non-clinical and administrative parts of the journey, including appointment requests, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, accommodation coordination, and bilingual administrative assistance during hospital visits. We are a medical concierge and logistics coordination provider; medical advice, diagnosis, treatment decisions, and clinical recommendations are provided by the relevant hospital or licensed specialist. Our role is to make the cross-border process more organized and easier to navigate.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking cardiovascular specialist-care pathways in Shanghai and elsewhere in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative assistance. MedBridgeNZ does not provide medical advice, diagnosis, or treatment; these are provided by independent hospitals and licensed specialists. Hospital, specialist, diagnostic, treatment, and travel charges are separate third-party costs unless expressly stated otherwise in writing.